Detail of the clinical trial

Title of the trial Adoptive transfer of haploidentical ex-vivo expanded NK cells in patients with refractory or relapsed acute myeloid leukemia followed by hematopoietic cell transplantation from haploidentical related donor after sequential conditioning regimen. A monocentric, single-dose escalation, open-label phase IIa study.
EudraCT number 2017-001119-35
Protocol number UHKT-CAML-NK-01
Sponsor Ústav hematologie a krevní transfuze (Institute of Hematology and Blood Transfusion),U Nemocnice 2094/1 ,Praha 2,128 20
Indications Hemato-oncology
Diagnosis acute myeloid leukemia
Population in clinical trial Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2017
Date of approval by Institute (SÚKL) 10.1.2018
Date of approval by EC
Date of initiation CT in ČR 3.4.2018
Date of ending CT in ČR
Notice
Sites Ústav hematologie a krevní transfuze,Transplant Unit and Hematological Intensive Care Unit ,U Nemocnice 2094/1 ,Praha 2,128 20

‹‹ Back to list